Clinical trial
The Short-term Effect of Immunomodulatory Treatment With Interferon Beta-1b (Betaferon) on Fatigue and Depression in First-time Treated Patients With Relapsing-remitting Multiple Sclerosis.
NCT01354665 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Short-term Effect of Immunomodulatory Treatment With Interferon Beta-1b (Betaferon) on Fatigue and Depression in First-time Treated Patients With Relapsing-remitting Multiple Sclerosis.
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- June 30, 2013
- Enrollment
- 567 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.